AGOMAB THERAPEUTICS NV AGMB
SPONSORED ADS · ADR · CUSIP 00860C102
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $12.98.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2026 | 32 |
| Q2 2026 | 34 |
Biggest buyers
| Redmile Group, LLC | Added | +2.6m |
| Nantahala Capital Management, LLC | Added | +1.9m |
| ORBIMED ADVISORS LLC | New | +192.7k |
| Aberdeen Group plc | Added | +139.0k |
| ALPS ADVISORS INC | New | +50.0k |
| Quadrature Capital Ltd | New | +20.5k |
| XTX Topco Ltd | New | +10.3k |
| CITIGROUP INC | New | +9.5k |
| TWO SIGMA INVESTMENTS, LP | Added | +3.8k |
| GAMMA Investing LLC | New | +1.3k |
Biggest sellers
| LMR Partners LLP | Sold out | -300.0k |
| SEVEN GRAND MANAGERS, LLC | Reduced | -152.4k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -95.2k |
| Alyeska Investment Group, L.P. | Sold out | -75.0k |
| Laurion Capital Management LP | Sold out | -50.0k |
| CITADEL ADVISORS LLC | Sold out | -35.0k |
| GOLDMAN SACHS GROUP INC | Reduced | -23.9k |
| D. E. Shaw & Co., Inc. | Sold out | -15.3k |
| JANE STREET GROUP, LLC | Sold out | -12.8k |
| HRT FINANCIAL LP | Reduced | -6.7k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
LSP 7 Cooperative UA
13D · may seek influence
new · filed 2026-02-17
Stated purposeAmended and Restated Shareholders' Agreement On November 4, 2024, certain shareholders of the Issuer, including LSP 7, entered into an amended and restated shareholders' agreement (the "Shareholders' Agreement") with the Issuer, pursuant to which the Issuer agreed, among other things, to register for resale certain Common Shares and other equity securities of the Issuer that are held by the parties (the "Registrable Securities"), and agreed to provide customary demand and "piggyback" registration rights, subject to certain requirements and conditions. The Shareholders' Agreement terminated immediately prior to the consummation of the IPO, except for the confidentiality provisions and registration rights granted thereunder. The registration rights granted under the Shareholders' Agreement… Full filing |
10.6% |
| FMR LLC 13G · institution new · filed 2026-03-06 | 10.0% |
| Pontifax Management 4 G.P. (2015) Ltd. 13G · exempt (held before listing) new · filed 2026-04-16 | 6.8% |
| Sanofi 13G · exempt (held before listing) new · filed 2026-05-06 | 5.7% |
| Redmile Group, LLC 13G · exempt (held before listing) new · filed 2026-05-15 | 5.6% |
| Cormorant Asset Management, LP 13G · institution new · filed 2026-05-15 | 5.0% |
Insider purchases and sales since 1 Apr 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported since 1 Apr 2026.
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| EQT Fund Management S.a r.l. 7.74% of their portfolio | 5.1m $66.7m | Unchanged |
| Nantahala Capital Management, LLC 1.23% of their portfolio | 3.1m $40.7m | Added +1.9m |
| Sanofi 6.76% of their portfolio | 2.8m $36.1m | Unchanged |
| Redmile Group, LLC 2.38% of their portfolio | 2.7m $35.5m | Added +2.6m |
| Cormorant Asset Management, LP 1.64% of their portfolio | 2.5m $32.0m | Unchanged |
| TCG Crossover Management, LLC 0.64% of their portfolio | 2.1m $26.7m | Unchanged |
| FEDERATED HERMES, INC. 0.03% of their portfolio | 1.6m $21.0m | Unchanged |
| Casdin Capital, LLC 1.01% of their portfolio | 1.6m $20.1m | Unchanged |
| ANDERA PARTNERS 9.67% of their portfolio | 1.5m $20.0m | Unchanged |
| FMR LLC 0.00% of their portfolio | 1.5m $18.9m | Unchanged |
| Aberdeen Group plc 0.02% of their portfolio | 846.7k $11.0m | Added +139.0k |
| PERCEPTIVE ADVISORS LLC 0.12% of their portfolio | 600.0k $7.8m | Unchanged |
| SAMSARA BIOCAPITAL, LLC 0.64% of their portfolio | 600.0k $7.8m | Unchanged |
| Siren, L.L.C. 0.11% of their portfolio | 411.2k $5.3m | Unchanged |
| ORBIMED ADVISORS LLC 0.05% of their portfolio | 192.7k $2.5m | New |
| Pfizer Inc 0.61% of their portfolio | 75.0k $1.0m | Unchanged |
| ALPS ADVISORS INC 0.00% of their portfolio | 50.0k $648.8k | New |
| Bellevue Group AG 0.01% of their portfolio | 49.2k $639.2k | Reduced -752 |
| SEVEN GRAND MANAGERS, LLC 0.02% of their portfolio | 47.6k $617.8k | Reduced -152.4k |
| SECTORAL ASSET MANAGEMENT INC 0.39% of their portfolio | 43.5k $564.6k | Unchanged |
| Burkehill Global Management, LP 0.02% of their portfolio | 35.0k $454.3k | Unchanged |
| Quadrature Capital Ltd 0.00% of their portfolio | 20.5k $265.6k | New |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 18.1k $234.6k | Added +3.8k |
| HRT FINANCIAL LP 0.00% of their portfolio | 17.1k $221.0k | Reduced -6.7k |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 11.8k $153.2k | Reduced -23.9k |
| XTX Topco Ltd 0.00% of their portfolio | 10.3k $133.3k | New |
| CITIGROUP INC 0.00% of their portfolio | 9.5k $123.3k | New |
| UBS Group AG 0.00% of their portfolio | 2.1k $27.6k | Reduced -4.3k |
| GAMMA Investing LLC 0.00% of their portfolio | 1.3k $17.4k | New |
| MORGAN STANLEY 0.00% of their portfolio | 1.2k $15.6k | Reduced -1.8k |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 754 $9.8k | New |
| Larson Financial Group LLC 0.00% of their portfolio | 698 $9.1k | New |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 2 $26 | Unchanged |
| Caitong International Asset Management Co., Ltd 0.00% of their portfolio | 2 $26 | New |